Patents Assigned to The Australia National University
  • Therapeutic compositions and methods for inhibition and treatment of tumor associated angiogenesis
    Patent number: 5874081
    Abstract: Antibodies, including monoclonal antibodies, specific for proliferating/angiogenic human endothelial cells such as human umbilical vein endothelial cells and human umbilical artery endothelial cells, and conjugates of these antibodies with a toxin material or label, are useful for inhibition of angiogenesis or for treatment of angiogenesis-dependent disease.
    Type: Grant
    Filed: March 13, 1997
    Date of Patent: February 23, 1999
    Assignee: The Australia National University
    Inventor: Christopher Richard Parish